Version 5.4
Bos taurus Gene: G2E3
Summary
InnateDB Gene IDBG-632212.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol G2E3
Gene Name G2/M phase-specific E3 ubiquitin-protein ligase
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000001617
Encoded Proteins
IDBP-683815
G2/M-phase specific E3 ubiquitin protein ligase
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000092140:
Gene Information
Type Protein coding
Genomic Location Chromosome 21:41640498-41686535
Strand Forward strand
Band
Transcripts
ENSBTAT00000002121 ENSBTAP00000002121
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004842 ubiquitin-protein transferase activity
GO:0005515 protein binding
GO:0008270 zinc ion binding
GO:0016874 ligase activity
GO:0046872 metal ion binding
Biological Process
GO:0000209 protein polyubiquitination
GO:0001824 blastocyst development
GO:2001243 negative regulation of intrinsic apoptotic signaling pathway
Cellular Component
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000092140
View Gene Order
ENSMUSG00000035293
View Gene Order
Cross-References
SwissProt
TrEMBL
UniProt Splice Variant
Entrez Gene
UniGene Bt.58897
RefSeq NM_001038671 XM_005222040 XM_005222041
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL
GenPept
RNA Seq Atlas

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca